LFST
LifeStance Health Group, Inc. · Healthcare · Medical - Care Facilities
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +10.0% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 94 | +6 | 202.79M | $2.17B | +9 | −4 |
| Q1 2026 | 92 | +4 | 167.71M | $1.07B | +8 | −4 |
| Q4 2025 | 88 | -1 | 153.78M | $1.08B | — | −1 |
| Q3 2025 | 18 | 0 | 91.69M | $504.30M | +1 | −1 |
| Q2 2025 | 15 | -1 | 76.22M | $394.07M | — | −1 |
| Q1 2025 | 13 | +1 | 23.58M | $157.08M | +2 | −1 |
| Q4 2024 | 12 | +3 | 19.00M | $140.00M | +4 | −1 |
| Q3 2024 | 8 | 0 | 11.91M | $83.39M | — | — |
| Q2 2024 | 8 | — | 9.89M | $48.56M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 38.99M | +29.4% | $214.47M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passive) | 17.48M | +43.8% | $96.13M | 0.0% | ▲ Add | 2 | SEC ↗ ×14 |
| 3 | The Vanguard Group ✦ (passive) | 14.61M | +19.5% | $80.37M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 4 | Geode Capital Management ✦ (passive) | 3.96M | +17.7% | $21.79M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | Goldman Sachs Group ✦ | 3.57M | — | $19.62M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 6 | State Street Global Advisors ✦ (passive) | 3.29M | +1.1% | $18.08M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Morgan Stanley ✦ | 3.12M | — | $17.16M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 8 | Millennium Management ✦ | 1.47M | -70.9% | $8.10M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 9 | Point72 Asset Management ✦ | 1.46M | -24.1% | $8.03M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Marshall Wace ✦ | 1.39M | New | $7.64M | 0.0% | New | 1 | SEC ↗ ×2 |
| 11 | AQR Capital Management ✦ | 671.07K | +2295.6% | $3.69M | 0.0% | ▲ Add | 4 | SEC ↗ ×4 |
| 12 | JPMorgan Chase ✦ | 481.31K | — | $2.65M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 13 | Renaissance Technologies ✦ | 477.20K | -64.7% | $2.62M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Adage Capital Partners ✦ | 450.00K | +63.6% | $2.48M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 94.85K | -93.3% | $521,675 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 81.45K | +3.8% | $448,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 74.12K | +55.9% | $407,638 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 15.09K | -95.4% | $83,012 | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $7.64M | 0.0% |
Exited
| Wellington Management | $23.64M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 226 holders, 368.43M shares, $2.34B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
10% owner · 18.41M sh · $226.26M
Officer · 42.07K sh · $541,402
Director · 7.50K sh · $95,100
Director · 20.44K sh · $249,993
Director · 500.00K sh · $5.75M
Officer · 44.39K sh · $481,675
Officer · 47.91K sh · $519,845
10% owner · 13.64M sh · $144.89M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology